Clinical TrialsSearch results
Number of results: 287
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Development of treatments for movement disorders by brain stimulation.
- central nervous system dysorders
- Etoh Seiji
- 2022-07-25
Recruiting
- Clinical study of Sakurajima Daikon
- Metabolic syndrome
- Ohishi Mitsuru
- 2022-03-30
Recruiting
- Phase II trial of Survivin-responsive oncolytic adenovirus (Surv.m-CRA-1) by repeated intratumoral injection in advanced bone tumor patients.
- Advanced primary malignant bone tumor
- Nagano Satoshi
- 2022-01-22
No Longer Recruiting
- A Phase I/II Study of RO4893594-PDS in Japanese Patients with Neovascular Age-Related Macular Degeneration and Japanese Patients with Diabetic Macular Edema
- Neovascular age-related macular degeneration (nAMD) and with diabetic macular edema (DME)
- Ogura Yuichiro
- 2021-10-02
Recruiting
- A Study of BIIB067 When Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation
- Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation
- Wong Janice
- 2021-06-09
Recruiting
- Study of the efficacy of MTA cement for root-end filling
- apical periodontitis, radicular cyst
- Katsumata Aiichiro
- 2021-04-07
Recruiting
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K delta Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
- Myelofibrosis, (Primary, Post Essential Thrombocythemia, Post Polycythemia Vera) Myelofibrosis
- Ueda Eiji
- 2021-03-17
Other
- A Phase 3, Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
- Hyperphosphatemia Patients on Hemodialysis
- Kinoshita Jun
- 2021-03-04
Other
- Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma
- Relapsed/Refractory Peripheral T-Cell Lymphoma, Including Adult T-Cell Leukemia/Lymphoma
- Inoguchi Akihiro
- 2021-01-29
Other
- A Clinical Efficacy and Safety Study of SHP607 in Preventing Chronic Lung Disease in Extremely Premature Infants
- Chronic Lung Disease
- Nishizawa Atsushi
- 2020-12-25